| Matthew Mollman, MD | |
|
2401 S 31st St, Temple, TX 76508-0001 | |
| (254) 724-2111 | |
| Not Available |
| Full Name | Matthew Mollman |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2401 S 31st St, Temple, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134500853 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | BP10053761 (Texas) | Primary |
| Entity Name | Slh Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881668051 PECOS PAC ID: 9830132653 Enrollment ID: O20050602000941 |
News Archive
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the lab of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "The Hepatitis C Virus (HCV) NS4B RNA Binding Inhibitor Clemizole is Highly Synergistic with HCV Protease Inhibitors".
The report from the congressional advisory group MedPAC assesses a variety of issues, including penalties that Medicare has recently begun imposing on hospitals and how that affects facilities largely serving poor patients.
In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants.
Antibiotics may not be the only risk factor associated with community-acquired Clostridium difficile infection, indicating that other undefined causes of the potentially life-threatening infection may exist and could also predict whether or not a patient will require hospitalization, according to the results of the study, "Predictors of Hospitalization in Community-Acquired Clostridium difficile Infection."
New research has shown that patients undergoing emergency surgery in lower income countries have a three times greater chance of dying than in higher income countries.
› Verified 5 days ago
| Entity Name | Ssm Health Care Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306589544 PECOS PAC ID: 0143608372 Enrollment ID: O20220531002655 |
News Archive
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the lab of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "The Hepatitis C Virus (HCV) NS4B RNA Binding Inhibitor Clemizole is Highly Synergistic with HCV Protease Inhibitors".
The report from the congressional advisory group MedPAC assesses a variety of issues, including penalties that Medicare has recently begun imposing on hospitals and how that affects facilities largely serving poor patients.
In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants.
Antibiotics may not be the only risk factor associated with community-acquired Clostridium difficile infection, indicating that other undefined causes of the potentially life-threatening infection may exist and could also predict whether or not a patient will require hospitalization, according to the results of the study, "Predictors of Hospitalization in Community-Acquired Clostridium difficile Infection."
New research has shown that patients undergoing emergency surgery in lower income countries have a three times greater chance of dying than in higher income countries.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Mollman, MD Po Box 840003, Dallas, TX 75284-0003 Ph: () - | Matthew Mollman, MD 2401 S 31st St, Temple, TX 76508-0001 Ph: (254) 724-2111 |
News Archive
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the lab of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "The Hepatitis C Virus (HCV) NS4B RNA Binding Inhibitor Clemizole is Highly Synergistic with HCV Protease Inhibitors".
The report from the congressional advisory group MedPAC assesses a variety of issues, including penalties that Medicare has recently begun imposing on hospitals and how that affects facilities largely serving poor patients.
In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants.
Antibiotics may not be the only risk factor associated with community-acquired Clostridium difficile infection, indicating that other undefined causes of the potentially life-threatening infection may exist and could also predict whether or not a patient will require hospitalization, according to the results of the study, "Predictors of Hospitalization in Community-Acquired Clostridium difficile Infection."
New research has shown that patients undergoing emergency surgery in lower income countries have a three times greater chance of dying than in higher income countries.
› Verified 5 days ago
Lucas Mark Alexander, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Baylor Scott & White Medical Center-temple, 2401 S 31st, Ms-11-ag062, Temple, TX 76508 Phone: 254-724-5815 | |
Amanda Zelinski, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Victoria Schneider Klovenski, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Van Steven Mask, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1901 Sw H K Dodgen Loop, Temple, TX 76502 Phone: 254-771-8600 | |
Dr. Jon E. Jaffe, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Robert D. Greenberg, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Caleb Cadis, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Dept Of Emergency Medicine 2401 S 31st St, Ms-11-ag062, Temple, TX 76508 Phone: 254-724-5815 |